Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients
Published: 23 February 2022| Version 1 | DOI: 10.17632/b323w45vm2.1
Contributor:
Description
This dataset was used in the paper "Preliminary Results of an Ongoing Prospective Clinical Trial on the Use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Staging of High-Risk Prostate Cancer Patients" published by Diagnostics in 2021 (doi.org/10.3390/diagnostics11112068). In this work we compared the performance of 68Ga-PSMA, 68Ga-DOTA-RM2 and MRI for the staging of PCa. All quantitative analysis can be reproduced by reading this dataset.
Files
Institutions
Ospedale San Raffaele
Categories
Positron Emission Tomography, Magnetic Resonance Imaging, Prostate Cancer